News Focus
News Focus
icon url

stockchase

05/30/19 1:24 PM

#5503 RE: ducatimunster #5501

From the last financials: "On January 18, 2019, Canandia received its B2B sales license for its Delta location (the “Delta Facility”) from Health
Canada pursuant to the Cannabis Act and Cannabis Regulations. The newly awarded license allows for the sale of final packaged flower, plants and seeds to Licensed Producers." So they can sell B2B not B2C

To me this means they can sell the dried packaged flower grown in their already built 4000 sq ft facility in Delta, thus the need to hire the master grower which joined recently

The corporate presentation had said they had planned on building out more sq footage but the financials show only 4000 that is already built as "planned" for 2019. I would think for the Mission facility they would need HC approval but maybe I am wrong.

As per the financials:

"Canandia has two properties: (1) a 4,000 square foot licensed cultivation facility located in Delta, British Columbia (“Delta Facility”), and (2) an additional property awaiting construction of a 50,000 square foot purpose-built indoor facility located in Mission, British Columbia (“Mission Location”)."

Invictus is on the hook for $10M to fund further buildouts, which is $10M they don't have right now so I think that is why they changed their square footage

IMO, they totally screwed this up with the lack of communication and the NASDAQ listing with the associated share split. I think they were going to use that to then do a financing and fund further expansion. When the share price plummetted, they have now been forced to sit tight on further expansion or do a seriously bad financing at these levels, which I really hope they are smart enough not to do, otherwise we will see much lower price than 44 cents IMO


icon url

Mrblabla

05/30/19 1:40 PM

#5504 RE: ducatimunster #5501

ABG looks to be on hold as management reviews options. After analyzing Health Canada regulations it is clear that marketing of "Branded" Cannabis products is essentially prohibited at this time.. The medical side can be marketed to thru clinics with info packets like with Invictus acquisition Leafwise.ca The recreational side is regulated by individual provinces who essentially buy the product from licensed producers and then "they" do the selling and marketing themselves through their dispensaries or online. Like I made mention only the approved growing facility and strain can be marketed, so this may have thrown a wrench in the big ABG branding push as it is a unique challenge and cannot be approached with the methods ABG are used to utilizing. I would say at best they are on hold or maybe gone for now IMO.
The Canandia excitement is based on the potential footprint and new license cost effectiveness to grow and expand (as you mentioned) under one license. They will be quite competitive with electricity costs due to location after analyzing and as far as I can tell Invictus needs to grow more product expeditiously and the new COO will coordinate the buildouts for all approved growing facilities moving forward, this is a wonderful move toward centralizing the focus and approval processing for each facility.
The new CFO is sharp and I think they are measuring things twice before they cut wood now.